Biopharmaceuticals Market Research Reports & Industry Analysis
Biopharmaceuticals are a class of drugs produced using living organisms or their cellular components to treat various medical conditions. By providing highly targeted and sophisticated therapeutic options, biopharmaceuticals have revolutionized the field of medicine. If you are in search of comprehensive and objective data on this fast-growing market, you have come to the right place. MarketResearch.com offers hundreds of biopharmaceuticals industry reports published by leading research firms.
New Biopharmaceuticals Market Research
- Use our reports to explore diverse markets in the biopharmaceuticals industry, from biosimilars to enzymes to antibodies.
- Gain invaluable insights, including biopharmaceuticals market size, growth, and industry trends.
- Get up to speed on the latest technological breakthroughs, opportunities, and market-entry strategies.
Proven Expertise in the Field of Market Research
With a track record spanning more than two decades, MarketResearch.com is a trusted source for market research. We serve top-tier investment banks, management consulting firms, and Fortune 500 multinational corporations. Our dedicated research specialists are here to provide recommendations and guidance throughout your research process. Improve your knowledge and enhance your strategies with biopharmaceutical market research from MarketResearch.com today.
Biopharmaceuticals Industry Research & Market Reports
-
Europe Sterile Tubing Welder Market Size, Share & Industry Trends Analysis Report By Mode (Automatic and Manual), By Application (Blood Processing, Diagnostic Laboratories, Biopharmaceutical, and Others), By End Use, By Country and Growth Forecast, 2022 - 2028
... - 2028 The Europe Sterile Tubing Welder Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028). Modern technology is anticipated to be installed on these sites. The need for sterile tubing ... Read More
-
Global Sterile Tubing Welder Market Size, Share & Industry Trends Analysis Report By Mode (Automatic and Manual), By Application (Blood Processing, Diagnostic Laboratories, Biopharmaceutical, and Others), By End Use, By Regional Outlook and Forecast, 2022 – 2028
... – 2028 The Global Sterile Tubing Welder Market size is expected to reach $2.9 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period. A sterile tubing welder is used ... Read More
-
North America Sterile Tubing Welder Market Size, Share & Industry Trends Analysis Report By Mode (Automatic and Manual), By Application (Blood Processing, Diagnostic Laboratories, Biopharmaceutical, and Others), By End Use, By Country and Growth Forecast, 2022 - 2028
... 2022 - 2028 The North America Sterile Tubing Welder Market would witness market growth of 5.0% CAGR during the forecast period (2022-2028). The demand for blood processing, sterile processing, and related infrastructure is expected to ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Single-Use Bioprocessing Probes And Sensors Market - Global Outlook & Forecast 2022-2027
... sensors are effective alternatives to traditional biopharmaceutical development and manufacturing methods. They are well-positioned to support the growing interest in the product's implementation of continuous bioprocessing. Conventional bioreactors and fermenters are made up of stainless ... Read More
-
Global Fill-finish Pharmaceutical Contract Manufacturing Market Size study, By Molecule Type (Large Molecules, Small Molecules), By Product Type (Prefilled Syringes, Vials, Cartridges, Others), By End-user (Biopharmaceutical Companies, Pharmaceutical Companies), and Regional Forecasts 2022-2028
... Pharmaceutical Contract Manufacturing Market is valued at approximately USD 8.25 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2028. Fill finish manufacturing ... Read More
-
Biosimilars Market Size By Product (Recombinant Non-Glycosylated Proteins {Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Interferon}, Recombinant Glycosylated Proteins {Erythropoietin, Monoclonal Antibodies, Follitropin, Low Molecular Weight Heparin}), By Application (Hematology {Neutropenia, Anemia}, Oncology {Lung Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA Technology, Monoclonal Antibodies Technology) Industry Analysis Report, Regional Outlook, Application Potential, COVID-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2030
... Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Leukemia or Blood Cancer}, Autoimmune Disease {Arthritis, Inflammatory Bowel Disease, Psoriasis}, Growth Hormone Deficiency, Diabetes), By Manufacturer (Contract Research and Manufacturing Services, In-house), By Technology (Recombinant DNA ... Read More
-
Global Bioprocessing Market (by Process, Technology, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)
... a CAGR of 11.49%, for the time period of 2022-2026. The factors such as growing sales of biotech, rising number of clinical trials, rise in cell culture practice, growth in biopharma merger & acquisition deals, ... Read More
-
Mini Bioreactors and Micro Bioreactors Market, 2022-2035
... witness significant growth in the next few years. However, it has been established that biologic drug development is a complex, time-consuming and capital-intensive process. These complex molecules require highly engineered specialized equipment, innovative downstream technologies, ... Read More
-
Regulatory Affairs Outsourcing Market - Global Outlook and Forecast 2022-2027
... market growth during the forecast period: Increasing Use of Digital Platforms/Solutions in Regulatory Affairs Changing Regulatory Landscape Rising Demand For Fast Drug & Medical Device Approvals Impact of Strict Government Regulations REGULATORY AFFAIRS OUTSOURCING MARKET ... Read More
-
Biosimilars Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change
... management with the critical information they need to assess the global biosimilars market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report ... Read More
-
Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027
... The global wound care biologics market is valued at an estimated USD 1.8billion in 2022 and is projected to reach USD 2.4billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth ... Read More
-
Global Regulatory Affairs Outsourcing Market Size study, by Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services) by Company Size (Small, Medium, Large) by Category (Drugs, Generics, Innovators, Biologics, Biotech, ATMPs, Biosimilars, Medical devices, Therapeutic, Diagnostic) by Indication (Oncology, Neurology, Cardiology, Immunology, Others) by Stage (Preclinical, Clinical, PMA (Post Market Authorization)) by End-use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies) and Regional Forecasts 2022-2028
... Innovators, Biologics, Biotech, ATMPs, Biosimilars, Medical devices, Therapeutic, Diagnostic) by Indication (Oncology, Neurology, Cardiology, Immunology, Others) by Stage (Preclinical, Clinical, PMA (Post Market Authorization)) by End-use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies) and Regional ... Read More
-
Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
... Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma, Generic] - Global Forecast to 2029 The Pharmaceutical Contract Development and Manufacturing Market is ... Read More
-
Biosimilars Market (Product: Recombinant Glycosylated Proteins, Recombinant Non-glycosylated Proteins, and Recombinant Peptides) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue ... Read More
-
Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028
... approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the ... Read More
-
Global GMP Testing Service Market Size study, by Service Type (Product Validation Testing, Bioanalytical Services, Packaging and Shelf-Life Testing, Other Service Types), by End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Devices Company) and Regional Forecasts 2022-2028
... Global GMP Testing Service Market is valued at approximately USD 1,161.23 million in 2021 and is anticipated to grow with a healthy growth rate of more than 6.97 % over the forecast period 2022-2028. GMPs ... Read More
-
Global Next-Generation Antibody Therapeutics Market: Market Segments: By Therapeutic Area (Oncology Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies, Fc-engineered Antibodies, Antibody Fragments and Antibody-like Proteins & Biosimilar Antibody Products);and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
... Size, Share & Trends for 2014 – 2019 and Forecasts to 2030 Product Overview Use of a new improvised therapeutic antibody to form novel medicines for the treatment of different diseases includes next-generation antibody therapeutics. ... Read More
-
Global Human Insulin Market: Market Segments: By Product (HI Drugs [HI Analogs, HI Biologics], HI Delivery Devices [Syringes, Pens, Pen Needles, and Pumps]); By Application (Type II Diabetes, Type I Diabetes, Gestational Diabetes & Prediabetes);and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
... Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030 Product Overview Insulin controls the metabolism of fat and carbohydrates in the body. It is a peptide hormone ... Read More
-
2022 Global Forecast for Anti-Inflammatory Biologics Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Biologics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... registering a CAGR of 9.22% during the forecast period, 2022-2027. With the growing COVID-19 burden, there has been a huge demand for biologics during the pandemic, which may drive the market growth. For instance, in ... Read More
-
Global Oncology Biosimilars Market Size study, By Indication (Atopic Dermatitis, Postoperative Immunosuppression, Ulcerative Colitis, Psoriasis, Keratoconjunctivitis, Others), By Drug Class (Cyclosporine, Tacrolimus, Pimecrolimus, Others), By Route of Administration (Oral, Topical, Parenteral), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028
... Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028 Global Oncology Biosimilars Market is valued approximately USD XX million in 2021 and is anticipated to grow with ... Read More
-
Colombia Wound Care Biologics Market, by Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), by Application (Chronic Wounds (Diabetic Foot Ulcer, Venous Leg Ulcer, and Pressure Ulcer) and Acute Wounds (Surgical Wounds
... and Burns)), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care Settings) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Wound is an injury to the body that typically involves breaking ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
MENA Biologics & Biosimilars Market, by Product Type (Influenza Vaccines, Factor VIII, (Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate and Novoeight), Erythropoietin (Epoetin Alfa
... and 4000IU) Darbepoietin Alfa (Aranesp) and Epoetin Alfa-epbx (Retacrit, Recormon)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP)), by Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), and by Region/Country (Gulf and Egypt) - Size, ... Read More
Research Assistance
